Kurs & Likviditet
Beskrivning
| Land | Norge |
|---|---|
| Lista | MERK Equities |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2021-12-29 11:52:32
An extraordinary general meeting of SoftOx Solutions AS (the "Company") was held
today on 29 December 2021 at 10.00. The general meeting was held as a video
conference meeting. 2 225 622 shares were represented, corresponding to 24 % of
the Company's total share capital.
The general meeting approved all the proposals on the agenda in line with the
notice dated 17 December 2021.
Signed minutes from the general meeting are attached to this announcement and
will be made available on the Company's website.
For further information, please contact:
CEO Geir Almås of SoftOx Solutions AS, or
CFO Kristine Rød of SoftOx Solutions AS
Mail: ir@soft-ox.com
Mobile: (+47) 948 59 599
About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian
BioTech company based in Oslo with the aim of helping to combat major threats to
human health, namely the emergence of antimicrobial resistance (AMR), biofilm
infections in chronic wounds and the spread of viruses. For more information on
SoftOx, visit www.soft-ox.com